Next-generation sequencing of 213 MDS patient samples identifies mutation profiles associated with response to hypomethylating agents and overall survival

被引：5

作者：

Bejar, R. ^{[1
]}

Stevenson, K. ^{[2
]}

Stojanov, P. ^{[3
]}

Zaneveld, J. E. ^{[4
]}

Bar-Natan, M.

Caughey, B. ^{[6
]}

Wang, H. ^{[4
]}

Garcia-Manero, G. ^{[7
]}

Kantarjian, H. ^{[7
]}

Cibulskis, K. ^{[3
]}

Getz, G. ^{[3
]}

Steensma, D. P. ^{[5
]}

Stone, R. M. ^{[5
]}

Chen, R. ^{[4
]}

Neuberg, D. ^{[2
]}

Ebert, B. L. ^{[8
]}

机构：

[1] Univ Calif San Diego, Hematol Oncol, San Diego, CA 92103 USA

[2] Dana Farber Canc Inst, Biostat & Computat Biol, Boston, MA 02115 USA

[3] Broad Inst, Canc Genome Computat Anal, Boston, MA USA

[4] Baylor Univ, Mol & Human Genet, Houston, TX 77030 USA

[5] Dana Farber Canc Inst, Med Oncol Leukemia, Boston, MA 02115 USA

[6] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA

[7] Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA

[8] Brigham & Womens Hosp, Hematol, Boston, MA 02115 USA

来源：

关键词：

D O I：

10.1016/S0145-2126(13)70046-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O-024

引用

页码：S19 / S20

页数：2